US FDA approves AbbVie drug for Parkinson's disease in adults
The health regulator's website showed the approval on Friday.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.
News Feed
2 results loaded, newest first. End of these results.
US FDA approves AbbVie's drug for Parkinson's disease
The US Food and Drug Administration has approved AbbVie's NYSE:ABBV drug for Parkinson's disease in adults, the health regulator's website showed on Friday.